一个可解释的机器学习评分工具,用于估计中风患者复发再入院的时间
Xiao Luo1, Xin Cui2, Rui Wang1
1Department of Military Health Statistics, Naval Medical University, Shanghai 200433, China.
International journal of medical informatics
|November 19, 2024
概括
一个新的中风复发再入院预测评分 (SSRRP) 工具准确地识别了面临90天再入院高风险的患者. 这种可解释的机器学习工具有助于针对性干预和对中风幸存者做出明智的临床决策.
科学领域:
- 医疗信息学 医疗信息学
- 心血管医学 心血管医学
- 公共卫生 公共卫生
背景情况:
- 脑卒中复发再入院造成了严重的患者和医疗负担.
- 准确的风险分层对于有针对性的干预来减少再接收至关重要.
- 预测短期和中期再接收风险有助于时间风险分层.
研究的目的:
- 开发和验证可解释的机器学习风险评分工具,用于预测中风复发再入院.
- 为加强风险分层提供准确的回收时间信息.
主要方法:
- 使用上海健康和健康发展研究中心数据库 (2015-2019) 进行的回顾性研究.
- 开发了中风复发再接收预测 (SSRRP) 的得分,使用可解释的机器学习来获得时间到事件的结果.
- SSRRP包含六个变量:后续,停留时间,中风类型,随机血葡萄糖,医疗费用支付和住院次数.
主要成果:
- 分析了339,212次中风入院病例;9.97%的人经历了90天的再入院.
- 在时间验证数据集中,SSRRP显示了0.730曲线下的集成区域.
- 该工具显示了良好的校准和临床益处率.
结论:
- SSRRP是一个节的,以点为基础的评分工具,用于预测复发性中风再入院风险.
- 该工具准确地提供回收时间数据,促进时间风险分层.
- SSRRP支持对中风患者管理的知情临床决策.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
09:10Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke
Published on: February 22, 2020
8.5K
相关概念视频
01:18Introduction To Survival Analysis
184
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
184
01:24Kaplan-Meier Approach
100
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
100